HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Caroline Le Poole Selected Research

HLA-A*02:01 antigen

1/2004Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Caroline Le Poole Research Topics

Disease

24Neoplasms (Cancer)
11/2021 - 02/2002
20Vitiligo
01/2021 - 01/2004
18Melanoma (Melanoma, Malignant)
01/2021 - 02/2002
4Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2020 - 12/2009
3Inflammation (Inflammations)
01/2021 - 01/2008
3Wounds and Injuries (Trauma)
08/2008 - 01/2004
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2004 - 01/2003
2Cysts
01/2020 - 01/2012
1Tuberous Sclerosis (Bourneville's Disease)
11/2021
1Dysbiosis
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Infections
09/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2013
1Dyspnea (Shortness of Breath)
01/2012
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2011
1Multiple Sclerosis
07/2011
1Disease Progression
07/2011
1Cutaneous Malignant Melanoma
04/2011
1Skin Neoplasms (Skin Cancer)
09/2008
1Autoimmune Diseases (Autoimmune Disease)
08/2008
1Microphthalmos
10/2004
1Venezuelan Equine Encephalomyelitis
01/2004
1Retinoblastoma (Glioblastoma, Retinal)
01/2004
1Papillomavirus Infections
01/2003
1Neoplasm Metastasis (Metastasis)
02/2002

Drug/Important Bio-Agent (IBA)

11AntigensIBA
01/2020 - 02/2002
6VaccinesIBA
01/2012 - 01/2003
5CytokinesIBA
02/2021 - 01/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2003
5Proteins (Proteins, Gene)FDA Link
09/2013 - 01/2004
4GangliosidesIBA
11/2021 - 07/2013
4Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2021 - 01/2004
4Peptides (Polypeptides)IBA
05/2016 - 02/2002
3lipoarabinomannan (LAM)IBA
01/2020 - 01/2012
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 07/2011
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 02/2013
3Monophenol Monooxygenase (Tyrosinase)IBA
02/2018 - 12/2009
3PhenolsIBA
03/2014 - 08/2008
3Differentiation AntigensIBA
07/2013 - 01/2004
2Chemokine CCL22IBA
10/2017 - 04/2010
2CCR4 ReceptorsIBA
10/2017 - 04/2010
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
08/2014 - 09/2013
2EpitopesIBA
08/2012 - 01/2004
2Bleaching AgentsIBA
06/2011 - 04/2011
2Interferon-gamma (Interferon, gamma)IBA
12/2009 - 02/2002
1Mechanistic Target of Rapamycin Complex 1IBA
11/2021
1TOR Serine-Threonine KinasesIBA
11/2021
1trans-sodium crocetinate (crocetin)IBA
11/2021
1Biomarkers (Surrogate Marker)IBA
02/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Amino AcidsFDA Link
01/2021
1AntibodiesIBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1Ampicillin (Omnipen)FDA LinkGeneric
01/2020
1Biological ProductsIBA
02/2018
1Interleukin-2 (IL2)IBA
02/2018
1alpha-N-acetylneuraminate alpha-2,8-sialyltransferaseIBA
01/2017
1Interleukin-4 (Interleukin 4)IBA
01/2017
1Chemotactic FactorsIBA
11/2016
1ChemokinesIBA
11/2016
1Toll-Like Receptor AgonistsIBA
08/2014
1Imiquimod (Aldara)FDA LinkGeneric
08/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2014
1Estrogen ReceptorsIBA
07/2013
1OxygenasesIBA
06/2011
1Heme (Haem)IBA
06/2011
1Protein Isoforms (Isoforms)IBA
06/2011
1Heme Oxygenase-1IBA
06/2011
1LigandsIBA
04/2010
1Phenol (Carbolic Acid)FDA Link
01/2010
1Pharmaceutical PreparationsIBA
01/2010
1Ether (Diethyl Ether)IBA
01/2010
1hydroquinone (Esoterica)FDA Link
01/2010
1Urokinase Plasminogen Activator ReceptorsIBA
11/2009
1Plasminogen Activators (Plasminogen Activator)IBA
11/2009
1G(M3) GangliosideIBA
11/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2008
1Basic Helix-Loop-Helix Transcription FactorsIBA
10/2004
1Microphthalmia-Associated Transcription FactorIBA
10/2004
1HLA-A*02:01 antigenIBA
01/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2004
1Cancer VaccinesIBA
11/2002
1interferon tauIBA
02/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2002

Therapy/Procedure

10Therapeutics
02/2021 - 02/2002
7Immunotherapy
11/2021 - 01/2003
1Lasers (Laser)
02/2002